Patents by Inventor Jérôme Clerc

Jérôme Clerc has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DEVELOPMENT OF A SYNTHESIS OF SYRINGOLIN A AND B AND DERIVATIVES THEREOF
    Publication number: 20100022767
    Abstract: The synthesis of syringolin A and B and derivatives thereof as well as to pharmaceutical compositions containing the syringolin A or B or derivatives thereof and the use of syringolin A and B and derivatives thereof for prophylaxis and treatment of cancer.
    Type: Application
    Filed: July 24, 2009
    Publication date: January 28, 2010
    Applicant: MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V.
    Inventors: Markus Kaiser, Jérôme Clerc
  • NUCLEIC ACIDS FOR EXPRESSING A POLYNUCLEOTIDE OF INTEREST IN MAMMALIAN CANCER CELLS
    Publication number: 20090318540
    Abstract: The invention relates to regulatory polynucleotides derived (i) from rat and human AFP promoter sequences and (ii) from rat and human HIP/PAPI promoter sequences, which regulatory polynucleotides are useful for expressing nucleic acids of interest specifically in mammalian cancer cells, including mammalian cancer liver cells.
    Type: Application
    Filed: September 12, 2007
    Publication date: December 24, 2009
    Applicant: INSERM (Institut National de la Sante et de la Recherche Medicale)
    Inventors: Jamilla Faivre, Julie Herve, Jérôme Clerc, Christian Brechot